Edna Maneval
Chief Tech/Sci/R&D Officer presso ORIC PHARMACEUTICALS, INC.
Profilo
Edna Chow Maneval is currently the Senior Vice President-Clinical Development at Oric Pharmaceuticals, Inc. She previously held positions as Vice President-Clinical Development at Aragon Pharmaceuticals, Inc., Seragon Pharmaceuticals, Inc., and.
Senior Vice President-Clinical Development at Ignyta, Inc. Dr. Maneval obtained a doctorate degree from the University of Southern California.
Posizioni attive di Edna Maneval
Società | Posizione | Inizio |
---|---|---|
ORIC PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2019 |
Precedenti posizioni note di Edna Maneval
Società | Posizione | Fine |
---|---|---|
IGNYTA INC | Corporate Officer/Principal | 01/01/2018 |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2014 |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2013 |
Formazione di Edna Maneval
University of Southern California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ORIC PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Edna Maneval